vimarsana.com
Home
Live Updates
Kezar Life Sciences Reports Third Quarter 2023 Financial Res
Kezar Life Sciences Reports Third Quarter 2023 Financial Res
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 13, 2023--
Related Keywords
San Diego ,
California ,
United States ,
South Korea ,
China ,
Thailand ,
Rohit Aggarwal ,
Gitanjali Jain ,
Christopher Kirk ,
John Fowler ,
Facebook ,
Exchange Commission ,
Clinical Development ,
Twitter ,
Asia Pacific League ,
Kezar Life Sciences Inc ,
Nasdaq ,
Instagram ,
American College Of Rheumatology ,
University Of Pittsburgh ,
Society For Immunotherapy Of Cancer ,
Kezar Life Sciences ,
Linkedin ,
Life Sciences ,
Chief Executive Officer ,
Everest Medicines ,
Chief Scientific ,
Selective Immunoproteasome ,
Greater China ,
Label Extension ,
American College ,
Broad Spectrum Sec ,
Annual Meeting ,
David Bade ,
Senior Scientist ,
Private Securities Litigation Reform Act ,
Investor Contact ,
Investor Relations ,
Business Wire ,
Region ,